Authors

• Ai‐Yan Xing
• Min Hee Hong (ORCID: https://orcid.org/0000-0003-3490-2195)
• Wentao Yang (ORCID: https://orcid.org/0000-0001-7712-822X)
• Hengli Ni (ORCID: https://orcid.org/0000-0003-2627-597X)
• Peng Gao (ORCID: https://orcid.org/0000-0003-3189-7263)
• Peilong Cao
• Hong Lv (ORCID: https://orcid.org/0000-0002-6624-1742)
• Huijuan Guan (ORCID: https://orcid.org/0000-0001-7595-3082)
• Guanjun Zhang (ORCID: https://orcid.org/0000-0003-1859-0443)
• Hongmei Wu (ORCID: https://orcid.org/0000-0002-1930-1183)
• Jun Fan (ORCID: https://orcid.org/0000-0002-5445-437X)
• Haifeng Yang (ORCID: https://orcid.org/0009-0000-6995-3940)
• Shiwei Xiao
• Qingfu Zhang (ORCID: https://orcid.org/0000-0002-9891-1296)
• Fangping Xu (ORCID: https://orcid.org/0000-0003-0692-0273)
• Jian‐Ming Li (ORCID: https://orcid.org/0000-0002-7999-2385)
• Lingfei Kong (ORCID: https://orcid.org/0000-0002-6626-2594)
• Xiu Nie
• Junqiu Yue (ORCID: https://orcid.org/0000-0002-1984-8445)

Institutions

• Union Hospital (HK)
• Sun Yat-sen University (CN)
• Fudan University Shanghai Cancer Center (CN)
• Sun Yat-sen Memorial Hospital (CN)
• First Affiliated Hospital of Xi'an Jiaotong University (CN)
• Henan Provincial People's Hospital (CN)
• First Hospital of China Medical University (CN)
• Guangdong Provincial People's Hospital (CN)
• Hubei Cancer Hospital (CN)
• Qilu Hospital of Shandong University (CN)
• Huazhong University of Science and Technology (CN)
• China Medical University (CN)

Publication Details

Journal

Breast Cancer Research

Published

2025-03-25

DOI

https://doi.org/10.1186/s13058-025-02001-0

Citations

14

Primary Topic

HER2/EGFR in Cancer Research

Type

article

Field-Weighted Citation Impact

14.64

Funders

• AstraZeneca
• Daiichi Sankyo Europe